ArticleMolecular diagnosis & therapy2019

Clinical Validation and Implementation of a Measurable Residual Disease Assay for NPM1 in Acute Myeloid Leukemia by Error-Corrected Next-Generation Sequencing.

Lauren L Ritterhouse et al.PubMed ↗Publisher ↗

No numbers read from the abstract.